• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 455/06 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems

Patent holdings for IPC class C07D 455/06

Total number of patents in this class: 109

10-year publication summary

5
8
23
17
21
13
4
2
2
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Auspex Pharmaceuticals, Inc.
208
17
Hoffmann-La Roche Inc.
3280
11
Neurocrine Biosciences, Inc.
407
9
F. Hoffmann-La Roche AG
7951
6
H. Lundbeck A/S
1244
6
Adeptio Pharmaceuticals Limited
21
5
Assia Chemical Industries Ltd.
85
4
Suzhou Ark Biopharmaceutical Co., Ltd.
17
4
The Regents of the University of Michigan
4595
3
The Trustees of the University of Pennsylvania
4273
3
Apotex Inc.
206
3
Newave Pharmaceutical Inc.
60
3
FUJIFILM Corporation
28841
2
Avid RadioPharmaceuticals, Inc.
24
2
Five Eleven Pharma Inc.
18
2
Sunshine Lake Pharma Co., Ltd.
572
2
Quixotic Holdings LLC
30
2
General Electric Company
17800
1
Sanofi-Aventis Deutschland GmbH
2605
1
The Trustees of Columbia University in the City of New York
3528
1
Other owners 22